An LC-MS/MS Validated Method for Quantification of Chlorzoxazone in Human Plasma and Its Application to a Bioequivalence Study.

J Chromatogr Sci 2019 Aug;57(8):751-757

Clinical Pharmacokinetics Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.

A simple, sensitive, specific, accurate liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay for determination of chlorzoxazone in human plasma was developed and validated to evaluate the pharmacokinetic characteristics of chlorzoxazone test or reference formulation. Sample preparation was achieved by one step protein precipitation and dilution with acetontrile. The chromatographic separation was performed at 40°C with a gradient mobile phase (0.3 mL/min) and a Shimadzu VP-ODS C18 analytical column (column size: 150 × 2.0 mm). TSQ quantum access triple-quadrapole MS/MS detection was operated in a negative mode by multiple reaction monitoring. Ion transitions at m/z 168.0→132.1 for chlorzoxazone and m/z 451.3→379.3 for repaglinide (internal standard) were used for the LC-MS/MS analysis. The calibration was linear (r ≥ 0.995) over the tested concentration range of 0.2-20 μg/mL for chlorzoxazone in plasma. Precision, accuracy, recovery, matrix effect and stability for chlorzoxazone were evaluated and were excellent within the range of tested concentrations. This method was successfully applied to a bioequivalence study in 20 healthy Chinese volunteers. This method could also contribute to the personalized medication and therapeutic drug monitoring of chlorzoxazone.

Download full-text PDF

Source
http://dx.doi.org/10.1093/chromsci/bmz052DOI Listing
August 2019
1 Read
1.363 Impact Factor

Publication Analysis

Top Keywords

human plasma
8
chlorzoxazone human
8
bioequivalence study
8
chlorzoxazone
7
detection operated
4
reaction monitoring
4
ms/ms detection
4
multiple reaction
4
mode multiple
4
negative mode
4
monitoring ion
4
operated negative
4
transitions m/z
4
4513→3793 repaglinide
4
repaglinide internal
4
internal standard
4
m/z 4513→3793
4
chlorzoxazone m/z
4
triple-quadrapole ms/ms
4
m/z 1680→1321
4

References

(Supplied by CrossRef)
Centrally acting skeletal-muscle relaxants
Domino et al.
Archives of Physical Medicine and Rehabilitation 1974
Development and validation of packed column supercritical fluid chromatographic technique for quantification of chlorzoxazone, paracetamol and aceclofenac in their individual and combined dosage forms
Desai et al.
Journal of Chromatographic Science 2012
Variability in the disposition of chlorzoxazone
de Vries et al.
Biopharmaceutics & Drug Disposition 1994
Molecular modeling of cytochrome P450 and drug metabolism
Wang et al.
Current Drug Metabolism 2010

Similar Publications